Association of Body Mass Index with disease severity among hospitalized patients with COVID-19: A retrospective cohort study
Pakistan Journal of Medical Sciences · 19.11.2026 · 42 (12) · 3486-3492
DOI: 10.12669/pjms.42.12.20280 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pakistan Journal of Medical Sciences, online erschienen am 19.11.2026. Verfasst von Hasan Ergenç und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
Obesity is an established risk factor for adverse outcomes in coronavirus disease 2019 (COVID-19), yet evidence regarding the association between body mass index (BMI) and disease severity in hospitalized patients remains limited. This study investigated the relationship between BMI, COVID-19 severity, and hospitalization outcomes.Methodology: This retrospective cohort study conducted at Ayancık State Hospital, Turkey; between March 1, 2021, and March 1, 2022. This study included 90 consecutive adults hospitalized with polymerase chain reaction-confirmed COVID-19. Patients were classified as underweight, normal weight, overweight, or obese according to BMI. Disease severity was categorized as mild, moderate, or severe based on national and World Health Organization criteria. Clinical characteristics, anthropometric measurements, and hospitalization outcomes were analyzed. Correlation analyses and multivariable logistic regression were performed to identify factors independently associated with severe disease.
Results
Among the 90 patients, 55.6% were obese and 31.1% were overweight. Disease severity differed significantly across BMI categories (two-sided Fisher–Freeman–Halton exact p=0.006), with overweight and obese patients more frequently presenting with moderate or severe disease. Mean BMI increased progressively with disease severity (25.5±5.2, 30.5±5.7, and 31.8±11.3 kg/m² for mild, moderate, and severe disease, respectively; p=0.001). Patients with more severe disease were older, more likely to have respiratory symptoms, and experienced longer hospital stays (p=0.044). BMI correlated positively with age (r=0.303, p=0.004) but not with length of hospital stay. In multivariable logistic regression, BMI was not independently associated with severe COVID-19 after adjustment for age, sex, and smoking status (aOR 1.06, 95% CI 0.98–1.15; p=0.139). Increasing age was independently associated with higher odds of severe disease (aOR 1.04, 95% CI 1.01–1.07; p=0.013), whereas female sex was associated with lower odds (aOR 0.27, 95% CI 0.10–0.73; p=0.010).
Conclusion
Higher BMI was associated with greater COVID-19 severity in unadjusted analyses but was not independently associated with severe disease after adjustment for age, sex, and smoking status. These findings should be considered exploratory given the retrospective, single-center design and limited sample size. Larger prospective multicenter studies are needed to clarify the independent prognostic role of BMI in hospitalized patients with COVID-19.
Zitieren
APA
Ergenç, H., Ergenç, Z., Kaya, G., & Karacaer, C. (2026). Association of Body Mass Index with disease severity among hospitalized patients with COVID-19: A retrospective cohort study. Pakistan Journal of Medical Sciences, 42(12), 3486-3492. https://doi.org/10.12669/pjms.42.12.20280
Vancouver
Ergenç H, Ergenç Z, Kaya G, Karacaer C. Association of Body Mass Index with disease severity among hospitalized patients with COVID-19: A retrospective cohort study. Pakistan Journal of Medical Sciences. 2026;42(12):3486-3492. doi:10.12669/pjms.42.12.20280
BibTeX
@article{Ergen2026,
author = {Ergenç, Hasan and Ergenç, Zeynep and Kaya, Gülsüm and Karacaer, Cengiz},
title = {Association of Body Mass Index with disease severity among hospitalized patients with COVID-19: A retrospective cohort study},
journal = {Pakistan Journal of Medical Sciences},
year = {2026},
volume = {42},
number = {12},
pages = {3486--3492},
doi = {10.12669/pjms.42.12.20280}
}
EUVIMED